We continue to thank IDSA’s 2018-19 Inclusion, Diversity, Access and Equity Task Force, pictured above at IDWeek in October, 2018: 1st row, left to right: Jasmine Marcelin, MD; Katie Bourgoin; Salandra Fleming; Tina Tan, MD, FIDSA. 2nd row, left to right: Raul Macias Gil, MD; Dawd Siraj, MD, FIDSA; Chris Busky, CAE; Janet Gilsdorf, MD, FIDSA, FPIDS; Ravina Kullar, PharmD, MPH, FIDSA; Paul Auwaerter, MD, MBA, FIDSA; Lilian Abbo, MD, FIDSA. Not pictured: Maria Alcaide, MD, FIDSA; Jose Caro, MD; Katherine Moyer, DO; Manal Youssef–Bessler, MD.
We’d like to provide an update on some of the Society’s Inclusion, Diversity, Access and Equity activities over the past few months. As you will recall, last October the Board reauthorized the IDA&E Task Force for an additional year with a charge to prioritize initiatives from the Roadmap and Strategies document created by the 2018-19 Task Force for implementation. Following a call for volunteers the 2020 members were selected in March, however activities as planned were placed on hold due to COVID-19.
Several weeks into the pandemic, the Task Force began working on initiatives that highlight the disproportionate impact the pandemic is having on vulnerable communities. In partnership with our Public Policy and HIVMA teams, we developed perspectives and policy briefs highlighting the impact of COVID-19 on underserved populations disproportionately impacted and included recommendations to reduce health disparities including Medicaid expansion, uniform data reporting on race and ethnicity, greater access to testing, protections for frontline workers, and housing and food assistance.
On June first, we released a statement in response to the tragic death of George Floyd, speaking out against systemic racism and related public health issues. The Task Force will continue to prioritize actions that will help end systemic racism pursuant to our mission and guiding principles in addition to supporting our broader IDA&E plans.
We look forward to keeping the membership community informed of our efforts to mitigate the impacts of COVID-19, as well as sharing our work applying the principles IDA&E throughout every facet of our Society.
Please join us in welcoming the members of the 2020 IDA&E Task Force:
- Tina Tan, MD, FIDSA (Chair)
- Hilary Babcock, MD, MPH, FIDSA, FSHEA
- Raul Macias Gil, MD
- Angelica Cifuentes Kottkamp, MD
- Ravina Kullar, PharmD, MPH, FIDSA
- Jasmine Riviere Marcelin, MD
- Carina Marquez, MD
- Trini A Mathew, MD, MPH, FIDSA
- Loren Nunley, MD, MBA
- Damani Piggott, MD, PhD
- Talia Swartz, MD, PhD
- Uzma Syed, DO
We are #IDA&E, we are #Diversity, the #FacesofID and #FutureofID